Omeros Corp. | Key People and Executives
Gregory A. Demopulos
Chairman, President & Chief Executive Officer
Peter A. Demopulos
Director
Leroy E. Hood
Independent Director
Thomas J. Cable
Lead Independent Director
Arnold C. Hanish
Independent Director
Ray Aspiri
Independent Director
Gregory A. Demopulos
Chairman, President & Chief Executive Officer
Michael A. Jacobsen
CFO, Treasurer, Chief Accounting Officer & VP
Eckhard Leifke
Chief Medical Officer & VP-Clinical Development
J. Steven Whitaker
Head-Clinical Aspects
George A. Gaitanaris
Chief Scientific Officer & VP-Science
Timi Edeki
Vice President-Clinical Development
Daniel M. Canafax
Vice President-Medical Affairs & Clinical Research
Leonard M. Blum
Chief Business & Commercial Officer
Kenneth M. Ferguson
Chief Development Officer & Vice President
Timothy M. Duffy
Vice President-Business Development
Peter A. Demopulos
Director
Patricia Sandler
Vice President-Sales & Marketing
Marcia S. Kelbon
Secretary, VP-Patents & General Counsel
Catherine A. Melfi
Chief Regulatory Officer & VP-Quality Systems
Leroy E. Hood
Independent Director
Thomas J. Cable
Lead Independent Director
Arnold C. Hanish
Independent Director
Ray Aspiri
Independent Director
| Address |
The Omeros Building
Seattle Washington 98119
United States
|
|
Employees
|
- |
| Website |
http://www.omeros.com |
| Updated |
07/08/2019 |
| Omeros Corp. operates as a biopharmaceutical company specializes in discovery, development, and commercializes of both small-molecule and protein therapeutics for large -market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA. |
